Invesco Ltd. Merrimack Pharmaceuticals Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 14, 2024	BUY	$13.06 - $15.0 $3.46 Million - $3.98 Million	265,058 Added 2196.73%	277,124 $4.09 Million
Q4 2023 Feb 12, 2024	BUY	$12.02 - $13.41 $145,033 - $161,805	12,066 New	12,066 $161,000
Q1 2023 May 12, 2023	BUY	$11.35 - $12.32 $2.39 Million - $2.59 Million	210,507 New	210,507 $2.59 Million
Q1 2020 May 15, 2020	SELL	$1.63 - $3.58 $82,613 - $181,445	-50,683 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.15 - $4.67 $10,533 - $15,616	-3,344 Reduced 6.19%	50,683 $160,000
Q3 2019 Nov 14, 2019	SELL	$4.16 - $6.05 $8,785 - $12,777	-2,112 Reduced 3.76%	54,027 $243,000
Q2 2019 Aug 14, 2019	SELL	$4.39 - $5.66 $8,499 - $10,957	-1,936 Reduced 3.33%	56,139 $340,000
Q1 2019 May 15, 2019	BUY	$3.19 - $5.73 $185,259 - $332,769	58,075 New	58,075 $404,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.